Australia - English - Department of Health (Therapeutic Goods Administration)

csl behring australia pty ltd - albumin, quantity: 25 g - injection, intravenous infusion - excipient ingredients: sodium chloride; sodium acetyltryptophanate; water for injections; sodium octanoate - restoration and maintenance of circulating blood volume where volume deficiency has been demonstrated and use of a colloid is appropriate. the choice of albumin rather than artificial colloid will depend on the clinical situation of the individual patient.

Australia - English - Department of Health (Therapeutic Goods Administration)

csl behring australia pty ltd - albumin, quantity: 200 g/l - injection, intravenous infusion - excipient ingredients: sodium; octanoate - hypoproteinaemia in the acutely ill patient albapure? 20 is administered when there are existing or anticipated clinical problems or complications from reduced oncotic pressure, and/or as an adjunct to diuretic therapy. shock: albapure? 20 may be used for the resuscitation of patients in shock due to acute loss of blood or plasma, but 4 - 5% human albumin is preferred when available. burns: extensive burns are followed by sequential shifts in the distribution of body water, salt and proteins resulting in hypovolaemic shock and circulatory failure.

Australia - English - Department of Health (Therapeutic Goods Administration)

csl behring australia pty ltd - albumin, quantity: 200 g/l - injection, solution - excipient ingredients: sodium; octanoate - hypoproteinaemia in the acutely ill patient albumex 20 is administered when there are existing or anticipated clinical problems or complications from reduced oncotic pressure, and/or as an adjunct to diuretic therapy. shock albumex 20 may be used for the resuscitation of patients in shock due to acute loss of blood or plasma, but 5% human albumin is preferred when available. burns extensive burns are followed by sequential shifts in the distribution of body water, salt and proteins, resulting in hypovolaemic shock and circulatory failure. initially (during the first 24 hours) there is an increased vascular permeability leading to loss of water and proteins into the extravascular compartment, and haemoconcentration. large volumes of crystalloid solutions should be infused to restore the constricted intravascular fluid space, and smaller amounts of albumex 20 are required to maintain adequate plasma volume and colloid osmotic pressure. adult respiratory distress syndrome the clinical syndrome is characteri

Australia - English - Department of Health (Therapeutic Goods Administration)

csl behring australia pty ltd - albumin, quantity: 12.5 g - injection, solution - excipient ingredients: sodium; chloride; octanoate - hypovolaemia/shock preservation of an adequate circulating blood volume should be the primary aim of therapy. the initial resuscitating fluid should not be a human blood product, but rather an alternative plasma volume expander should be used as first-line replacement. albumex 5 may, however, be the initial plasma expander of choice if shock is associated with significant hypoalbuminaemia (albumin concentration less than 25 g/litre), or if it is clinically desirable to avoid the infusion of large volumes of crystalloid solutions. albumex 5 may also be useful following initial resuscitation with crystalloid or synthetic colloid solutions in patients in whom extended support of the intravascular volume is required, such as seriously ill patients with multiple organ failure or the systemic capillary leak syndrome. cardiopulmonary bypass albumex 5 may be used for priming the pump for cardiopulmonary bypass surgery for patients with poor left ventricular function, and other complicating factors such as long byp

Australia - English - Department of Health (Therapeutic Goods Administration)

csl behring australia pty ltd - albumin, quantity: 200 g/l - injection, solution - excipient ingredients: sodium; octanoate - hypoproteinaemia in the acutely ill patient - albapure 20 is administered when there are existing or anticipated clinical problems or complications from reduced oncotic pressure, and/or as an adjunct to diuretic therapy. shock - albapure 20 may be used for the resuscitation of patients in shock due to acute loss of blood or plasma. severe burns - extensive burns are followed by sequential shifts in the distribution of body water, salt and proteins, resulting in hypovolaemic shock and circulatory failure. iso-oncotic albumin solution is the preferred replacement material. if the patient's serum albumin level is not maintained, concentrated albumin (20%) may be indicated. if exchange occurs less frequently than once a week, less concentrated colloids may be appropriate.

Australia - English - Department of Health (Therapeutic Goods Administration)

csl behring australia pty ltd - albumin, quantity: 200 g/l - injection, solution - excipient ingredients: sodium; octanoate - 1. hypoproteinaemia in the acutely ill patient. albapure 20 is administered when there are existing or anticipated clinical problems or complications from reduced oncotic pressure, and/or as an adjunct to diuretic therapy. 2. shock. albapure 20 may be used for the resuscitation of patients in shock due to acute loss of blood or plasma, but 4-5% human albumin is preferred when available. 3. burns. extensive burns are followed by sequential shifts in the distribution of body water, salt and proteins, resulting in hypovolaemic shock and circulatory failure. initially (during the first 24 hours) there is an increased vascular permeability leading to loss of water and proteins into the extravascular compartment, and haemoconcentration. large volumes of crystalloid solutions should be infused to restore the constricted intravascular fluid space, and smaller amounts of albapure 20 are required to maintain adequate plasma volume and colloid osmotic pressure. 4. adult respiratory distress syndrome. the clinical s

Australia - English - Department of Health (Therapeutic Goods Administration)

csl behring australia pty ltd - albumin, quantity: 0.2 g/ml - injection, solution - excipient ingredients: sodium; octanoate - hypoproteinaemia in the acutely ill patient albumex 20 is administered when there are existing or anticipated clinical problems or complications from reduced oncotic pressure, and/or as an adjunct to diuretic therapy. shock: albumex: 20 may be used for the resuscitation of patients in shock due to acute loss of blood or plasma, but 4-5% human albumin is preferred when available. burns: extensive burns are followed by sequential shifts in the distribution of body water, salt and proteins, resulting in hypovolaemic shock and circulatory failure. initially (during the first 24 hours) there is an increased vascular permeability leading to loss of water and proteins into the extravascular compartment, and haemoconcentration. large volumes of crystalloid solutions should be infused to restore the constricted intravascular fluid space, and smaller amounts of albumex 20 are required to maintain adequate plasma volume and colloid osmotic pressure. adult respiratory distress syndrome: the clinical syndrome is charac

Australia - English - Department of Health (Therapeutic Goods Administration)

csl behring australia pty ltd - albumin, quantity: 200 g/l - injection, solution - excipient ingredients: sodium; octanoate - hypoproteinaemia in the acutely ill patient albapure 20 is administered when there are existing or anticipated clinical problems or complications from reduced oncotic pressure, and/or as an ajunct to diurectic therapy. although intravenous . shock albapure 20 may be used for the resuscitation of patients in shock due to acute loss of blood or plasma, but 4-5% human albumin is preferred when available. burns extensive burns are followed by sequential shifts in the distribution of body water, salt and proteins resulting in hypovolaemic shock and circulatory failure. initially (during the first 24 hours) there is an increased vascular permeability leading to loss of water and proteins into the extravascular compartment, and haemoconcentration. large volumes of crystalloid solutions should be infused to restore the constricted intravascular fluid space, and smaller amounts of albpure 20 are required to maintain adequate plasma volume and colloid osmotic pressure. adult respiratory distress syndrome the

Australia - English - Department of Health (Therapeutic Goods Administration)

csl behring australia pty ltd - albumin, quantity: 200 g/l - injection, solution - excipient ingredients: sodium; octanoate - other conditions: protct from light 1. hypoproteinaemia in acutely ill patients: (a) to increase oncotic pressure (b) as an adjunct to diuretic therapy (c) as a nutrient in paediatrics. 2. resuscitation. in shock due to acute blood or plasma loss together with crystalloid solutions. 3. burns. to maintain colloid osmotic pressure. 4. adult respiratory distress syndrome - used with diuretics. 5. haemodialysis - assists in the rapid removal of excess extravascular fluid and maintain perfusion pressure. 6. therapeutic plasma exchange - used when a patients' serum albumin level is not maintained.

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

biotest (uk - albumin solution human - solution for infusion - 50mg/1ml